Babycell, a brand of Regenerative Medical Services Pvt Ltd (India’s only company in FDA approved Stem Cell Therapy in association with Apollo hospital) is India’s premium cord blood bank. Babycell has a presence in 200+ locations with over 19000+ happy families!
Regenerative Medical Services (RMS) is known for its best in class Cord Blood Banking Facility (Babycell), innovative technology and stem cell therapy in India with a reputation in transparency, excellence and quality. We are growing at an ambitious pace. This offers you greater opportunities to advance in your career as you help improve the quality of life. In our continuous effort to provide unmatched careers, we are focusing on three key themes for employees - help us build a greater next century; share in our success; and create robust and sustainable brand equity.
Preserving umbilical cord blood and tissue can help treat 80+ life threatening diseases and is an investment for entire family’s future health. The use of umbilical cord blood stem cells has increased significantly all across the world. Indian Stem Cell Banking market currently valued at 1 billion and is expected to reach INR 2 Billion by 2018. The stem cell banking market in India is growing at a CAGR of 37.85% over the period 2014-2019. The future is quite bright for this industry as the consumer healthcare market is advancing towards preventive care with Babycell being one of the fastest growing cord blood banks in India.
Please visit our website- www.babycell.in / www.dontignorepain.com